Source link : https://www.mondialnews.com/2026/04/24/trump-administration-reclassifies-medical-marijuana-as-a-lower-risk-drug/
In a significant shift in U.S. drug policy, the Trump administration has reclassified medical marijuana as a “less-dangerous drug,” easing federal restrictions on its use and possession. The announcement marks a departure from previous policies that categorized marijuana alongside substances considered to have high potential for abuse and no accepted medical benefits. This reclassification is expected to impact medical marijuana patients, researchers, and the broader debate over cannabis legalization nationwide. The move has sparked varied reactions from lawmakers, advocacy groups, and health experts, highlighting the complex landscape surrounding cannabis regulation in the United States.
Trump Administration Shifts Medical Marijuana Classification in Landmark Policy Change
In a significant departure from previous federal policy, the Trump administration has officially reclassified medical marijuana, shifting it from the highest federal drug category to a designation reflecting a *reduced risk potential*. This move acknowledges growing scientific evidence of cannabis’s therapeutic benefits and marks a crucial step toward reconciling federal law with the increasing number of states legalizing cannabis-based treatments. The reclassification not only impacts regulatory frameworks but could also pave the way for expanded research and easier patient access nationwide.
- Reclassification details: Marijuana has been moved from Schedule I, reserved for substances with “no…
—-
Author : Ava Thompson
Publish date : 2026-04-24 00:23:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8